サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1712509

組織レベルインプラントの世界市場：2025年～2033年

Global Tissue Level Implant Market - 2025-2033

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
組織レベルインプラントの世界市場：2025年～2033年
出版日: 2025年04月22日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の組織レベルインプラントの市場規模は、2024年に94億2,000万米ドルとなりました。同市場は、2033年には163億8,000万米ドルに達し、2025年から2033年の予測期間中に6.9％のCAGRで拡大すると予測されています。

組織レベルインプラントは、インプラントとアバットメント間の界面が骨レベルより上に位置し、歯肉組織と直接接触するユニークな設計を特徴とする特殊な歯科インプラントの一種です。この設計は、治癒プロセス、患者ケア、インプラントの全体的な効果にいくつかの重要な意味を持っています。

高齢者人口の増加と歯科疾患の負担の増加、高齢者人口の増加と歯科疾患の負担の増加、技術の進歩が市場の成長を促進すると予想されます。人は高齢になるにつれ、虫歯、歯周病、経年摩耗などの要因により歯を失う可能性が高くなります。高齢者層は、口腔機能と審美性を回復するための長期的なソリューションとして歯科インプラントを考慮することが多く、組織レベルのインプラントに対する需要が増加しています。

高齢者人口の増加と歯科疾患の負担増が市場成長の原動力になると予想されます。高齢になると、虫歯、歯周病、経年摩耗などの要因により、歯を失う可能性が高くなります。高齢者層は、口腔機能と審美性を回復するための長期的なソリューションとして歯科インプラントを頻繁に検討し、組織レベルのインプラントに対する需要を増加させています。

例えば、2024年のHerman Ostrow School of Dentistry of USCのレポートによると、65歳以上の成人の約5％が無歯顎であると推定されています。さらに、2023年の世界保健機関（WHO）の報告によると、口腔疾患は約35億人に影響を及ぼすと推定されています。歯科疾患の増加は、組織レベルのインプラント需要を増加させ、市場成長を促進します。

さらに、パートナーシップ＆コラボレーション、製品発売などの主要参入企業の戦略は、この市場成長を促進すると思われます。例えば、2022年11月、Prayastaという新興企業がインド科学研究所（IISc）と共同で、Silimacと名付けられた世界初のインプラントグレードシリコーン用3Dプリンターを開発しました。この革新的な技術は、IIScのバイオシステム科学・工学センター（BSSE）で発表され、病院内でパーソナライズされたシリコンインプラントを直接3Dプリントできるように設計されています。

組織レベルのインプラントのコストが高いことは、世界市場における大きな抑制要因であり、患者の利用を制限し、ヘルスケアプロバイダーに課題をもたらしています。組織レベルのインプラントには、チタン、ジルコニア、先端ポリマーなどの高品質の生体適合材料が必要であり、コストがかかります。精密な製造と滅菌工程は、全体的な出費に拍車をかける。インプラント技術には、安全性、耐久性、人体組織との適合性を確保するための広範な研究開発が含まれます。したがって、上記の要因が世界の組織レベルインプラント市場の潜在的成長を制限している可能性があります。

当レポートでは、世界の組織レベルインプラント市場について調査し、市場の概要とともに、タイプ別、材質別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 経営者の洞察と重要なポイント

第3章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーとパイオニア
  • CXOの視点
  • 最新の開発とブレークスルー
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第5章 組織レベルインプラント市場（タイプ別）

  • 心血管インプラント
  • 歯科インプラント
  • 乳房インプラント
  • 顔面インプラント
  • 整形外科インプラント
  • その他

第6章 組織レベルインプラント市場（材質別）

  • チタン
  • ジルコニア
  • コバルトクロム合金
  • ポリエーテルエーテルケトン
  • ポリプロピレン
  • その他

第7章 組織レベルインプラント市場（エンドユーザー別）

  • 病院と診療所
  • 歯科医院
  • 外来手術センター
  • その他

第8章 組織レベルインプラント市場、地域別市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • 南米
    • ブラジル
    • アルゼンチン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 中東・アフリカ

第9章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要市場参入企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併・買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第10章 企業プロファイル

  • Institut Straumann AG
    • 会社概要
    • 製品ポートフォリオ
    • 財務概要
    • 主な発展
    • SWOT分析
  • Nobel Biocare Services AG
  • Dentsply Sirona
  • Zimmer Biomet
  • Biotech Dental
  • BioHorizons
  • TBR Dental
  • Hiossen Implant Canada INC.
  • Southern Implant
  • Implant Direct

第11章 仮定と調査手法

第12章 付録

目次
Product Code: MD4253

The global tissue-level implant market reached US$ 9.42 billion in 2024 and is expected to reach US$ 16.38 billion by 2033, growing at a CAGR of 6.9 % during the forecast period of 2025-2033.

Tissue-level implants are a specialized type of dental implant characterized by their unique design, where the interface between the implant and the abutment is positioned above the bone level, directly in contact with the gum tissue. This design has several important implications for the healing process, patient care, and overall effectiveness of the implant.

The increasing geriatric population and the increasing burden of dental diseases, Rising geriatric population and burden of dental diseases, and technological advancements are expected to drive the market growth. People are more likely to lose teeth as they become older due to factors like decay, gum disease, and wear over time. The senior population frequently considers dental implants as a long-term solution for restoring oral function and aesthetics, increasing demand for tissue-level implants.

Market Dynamics: Drivers & Restraints

Increasing Demand for Dental Implants

The increasing geriatric population and the increasing burden of dental diseases are expected to drive the market growth. People are more likely to lose teeth as they become older due to factors like decay, gum disease, and wear over time. The senior population frequently considers dental implants as a long-term solution for restoring oral function and aesthetics, increasing demand for tissue-level implants.

For instance, according to the report by the Herman Ostrow School of Dentistry of USC in 2024, it is estimated that around 5% of adults older than 65 years are edentulous. Additionally, according to the report by the World Health Organization in 2023, it is estimated that oral diseases affect nearly 3.5 billion people. The increasing number of dental diseases increases demand for tissue-level implants and drives market growth.

Furthermore, key players' strategies such as partnerships & collaborations, and product launches would drive this market growth. For instance, in November 2022, a startup named Prayasta, in collaboration with the Indian Institute of Science (IISc), developed the world's first 3D printer for implant-grade silicone, named Silimac. This innovative technology was unveiled at the IISc's Centre for BioSystems Science and Engineering (BSSE) and is designed to directly 3D print personalized silicone implants within a hospital setting.

High Costs of Implants

The high cost of tissue-level implants is a significant restraint in the global market, limiting accessibility for patients and creating challenges for healthcare providers. Tissue-level implants require high-quality biocompatible materials such as titanium, zirconia, or advanced polymers, which are costly. The precision manufacturing and sterilization processes add to the overall expense. Implant technology involves extensive R&D to ensure safety, durability, and compatibility with human tissues. Thus, the above factors could be limiting the global tissue-level implant market's potential growth.

Segment Analysis

The global tissue-level implant market is segmented based on type, material, end-user, and region.

Type:

The dental implant segment in type is expected to dominate the global tissue-level implant market with the highest market share

Dental implants are an artificial solution for tooth replacement, designed to provide a permanent and functional alternative to traditional prosthetics such as dentures and bridges. The rise in dental diseases, particularly periodontal disease and dental caries, is a significant driver of demand for dental implants. This demand is largely fueled by the consequences of these conditions, which often lead to tooth loss and the subsequent need for effective replacement solutions.

According to WHO data in March 2023, the prevalence of dental diseases, particularly dental caries and periodontal disease, is a significant public health concern globally. An estimated 2 billion people suffer from caries of permanent teeth, and 514 million children are affected by caries of primary teeth. This widespread occurrence is exacerbated by factors such as urbanization and changing living conditions, which contribute to the increasing prevalence of these oral diseases.

Innovations in materials, technology, and surgical techniques have enhanced the appeal of dental implants among both patients and practitioners. As advancements continue to evolve within this field, dental implants are increasingly recognized as the gold standard for tooth replacement solutions, offering lasting benefits that align with modern expectations for oral health and aesthetics.

Furthermore, key players in the industry product launchers that would drive this market growth. For instance, Nobel Biocare introduced two advanced surfaces for dental implants: Xeal for abutments and TiUltra for implants. These surfaces leverage Nobel Biocare's extensive expertise in anodization technology, which is crucial for optimizing tissue integration at every level of the implant system, from the abutment to the apex.

For instance, in March 2022, Bredent Medical launched a new generation of whiteSKY zirconia implants, enhancing its existing line of ceramic dental implants. This updated implant system is designed to meet the growing demand for aesthetic and biocompatible dental solutions, particularly for patients who prefer metal-free options. These factors have solidified the segment's position in the global tissue-level implant market.

Geographical Analysis

North America is expected to hold a significant position in the global tissue-level implant market with the highest market share

There is an increasing number of periodontal diseases in the North America region. Gum (periodontal) disease is a broad term for gingivitis and periodontitis. These conditions involve infection and inflammation of the tissues (e.g., gum and bone) around the teeth.

For instance, according to the World Health Organization (WHO), the most common oral health conditions include cavities, gum disease, tooth loss, and oral cancer. About 90% of U.S. adults 20 years and older have experienced at least one cavity. Nearly half (42%) of U.S. adults have periodontal (gum) disease. Thus, the above factors are expected to hold the region in the dominant position during the forecast period.

Continuous innovations in implant materials (like titanium and zirconia), design, and surgical techniques have improved the success rates of tissue-level implants. Enhanced biocompatibility and osseointegration properties make these implants more appealing to both patients and healthcare providers. Moreover, in this region, a majority of key players' presence, well-advanced healthcare infrastructure, government initiatives & regulatory support, technological advancements, & investments, and product launches & approvals would propel this market growth.

For instance, in February 2024, American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, Anika Therapeutics launched the Integrity Implant System and the RevoMotion Reverse Shoulder Arthroplasty System, along with other key regenerative products. This event is a significant gathering for orthopedic professionals, showcasing the latest advancements in orthopedic surgery and rehabilitation.

Similarly, in June 2023, the FDA approved the SNUCONE Co., Ltd., developed the SNUCONE Tissue Level Implant System, which is designed for use in dental applications, specifically for partially or fully edentulous (toothless) mandibles (lower jaw) and maxillae (upper jaw). The system is intended to support single or multiple dental restorations, making it a versatile option for patients requiring dental implants. Thus, the above factors are consolidating the region's position as a dominant force in the global tissue-level implant market.

Competitive Landscape

The major global players in the tissue-level implant market include Institut Straumann AG, Nobel Biocare Services AG, Dentsply Sirona, Zimmer Biomet, Biotech Dental, BioHorizons, TBR Dental, Hiossen Implant Canada INC., Southern Implant, and Implant Direct, among others.

Key Developments

  • In January 2023, MediNiche introduced Bone-Tite, the first dietary supplement specifically designed for dental implant patients. Bone-Tite aims to provide nutritional support before and after dental implant procedures, addressing the critical role that nutrition plays in the osseointegration process and the integration of the implant with the surrounding bone.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global tissue-level implant market report delivers a detailed analysis with 62 key tables, more than 59 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Material
  • 2.5. Snippet by End-User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing Demand for Dental Implants
      • 3.1.1.2. Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. High Costs of Implants
      • 3.1.2.2. Difficulties Associated with Tissue Implants
    • 3.1.3. Opportunity
      • 3.1.3.1. Expansion in Emerging Markets
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with the largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Regulatory and Reimbursement Landscape
    • 4.4.1. North America
    • 4.4.2. Europe
    • 4.4.3. Asia Pacific
    • 4.4.4. South America
    • 4.4.5. Middle East & Africa
  • 4.5. Porter's Five Forces Analysis
  • 4.6. Supply Chain Analysis
  • 4.7. Patent Analysis
  • 4.8. SWOT Analysis
  • 4.9. Unmet Needs and Gaps
  • 4.10. Recommended Strategies for Market Entry and Expansion
  • 4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.12. Pricing Analysis and Price Dynamics
  • 4.13. Key Opinion Leaders

5. Tissue Level Implant Market, By Type

  • 5.1. Introduction
    • 5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index By Type
  • 5.2. Cardiovascular Implants*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Dental Implant
  • 5.4. Breast Implant
  • 5.5. Facial Implant
  • 5.6. Orthopaedic Implants
  • 5.7. Others

6. Tissue Level Implant Market, By Material

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 6.1.2. Market Attractiveness Index By Material
  • 6.2. Titanium*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Zirconia
  • 6.4. Cobalt-Chromium Alloys
  • 6.5. Polyetheretherketone
  • 6.6. Polypropylene
  • 6.7. Others

7. Tissue Level Implant Market, By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals & Clinics*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Dental Clinics
  • 7.4. Ambulatory Surgical Centers
  • 7.5. Others

8. Tissue Level Implant Market, By Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
      • 8.2.6.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Brazil
      • 8.4.6.2. Argentina
      • 8.4.6.3. Rest of South America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Institut Straumann AG*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Nobel Biocare Services AG
  • 10.3. Dentsply Sirona
  • 10.4. Zimmer Biomet
  • 10.5. Biotech Dental
  • 10.6. BioHorizons
  • 10.7. TBR Dental
  • 10.8. Hiossen Implant Canada INC.
  • 10.9. Southern Implant
  • 10.10. Implant Direct

LIST NOT EXHAUSTIVE

11. Assumptions and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us